SUBATVAX Trademark

Trademark Overview

On Friday, January 27, 2023, a trademark application was filed for SUBATVAX with the United States Patent and Trademark Office. The USPTO has given the SUBATVAX trademark a serial number of 97770655. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, October 2, 2024. This trademark is owned by D4 Labs LLC. The SUBATVAX trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for use with vaccines
subatvax

General Information

Serial Number97770655
Word MarkSUBATVAX
Filing DateFriday, January 27, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, October 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements

Goods and ServicesAdjuvants for use with vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code005
First Use Anywhere DateWednesday, January 24, 2024
First Use In Commerce DateWednesday, January 24, 2024

Trademark Owner History

Party NameD4 Labs LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPacific Grove, CA 93950
Party NameD4 Labs LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPacific Grove, CA 93950

Trademark Events

Event DateEvent Description
Tuesday, January 31, 2023NEW APPLICATION ENTERED
Wednesday, February 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 25, 2023ASSIGNED TO EXAMINER
Thursday, October 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 25, 2024USE AMENDMENT FILED
Thursday, July 25, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, July 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, September 27, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 2, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

subatvax vaccines adjuvants